LEIPZIG, Germany, September 26, 2019 / B3C newswire / -- Leading global genomics services provider, GENEWIZ, a Brooks Life Sciences Company, announced the opening of its European headquarters for its genomics business in Leipzig, Germany. This centralized …
BASEL, Switzerland, September 26, 2019 / B3C newswire / -- T3 Pharmaceuticals AG (T3), a Basel (Switzerland)-based company focusing on immuno-oncology, closes its second financing round of over 12M CHF with existing investors joined by «Boehringer …
NAARDEN, The Netherlands, September 25, 2019 / B3C newswire / -- NorthSea Therapeutics B.V., (‘NST’) a Dutch biotech company developing novel and innovative strategies for the treatment of NASH (Non-alcoholic Steatohepatitis) and other metabolic, …
HEIDELBERG, Germany, September 23, 2019 / B3C newswire / -- BioMed X announced today the completion of their first research collaboration project with Roche Diagnostics in the field of nanomaterial-based biosensors for near patient testing. BioMed X …
Mimetas congratulates chairman with well-deserved Royal award LEIDEN, the Netherlands, September 19, 2019 / B3C newswire / -- Herbert ‘Herb’ Heyneker, Chairman of the Board of Directors at Mimetas and Dutch biotech pioneer, has been honored by the Dutch …
Winning companies recognized for making better business, creating richer lives and building a stronger community as a whole SKOKIE, Illinois & RAVENSBURG, Germany, September 18, 2019 / B3C newswire / -- Vetter, a globally operating Contract …
GRONINGEN, The Netherlands, September 17, 2019 / B3C newswire / -- Polyganics, a medical technology company developing, manufacturing and commercializing bioresorbable medical devices, has today announced positive data from its ENCASE I* clinical trial …
Investment provides 19.2% stake in Autolus Autolus is PPF’s second largest investment in the healthcare sector, after PPF’s majority-owned biotechnology company SOTIO PRAGUE, Czech Republic, September 16, 2019 / B3C newswire / -- PPF today announces the …
Bioinformatic software is the basis for development in the automated relevance-based detection of blood-stream infections DUISBURG, Germany, September 10, 2019 / B3C newswire / -- Noscendo GmbH today announced the successful completion of the development …
BERLIN, Germany, September 10, 2019 / B3C newswire / -- ProBioGen AG, a premier service and technology provider for complex therapeutic antibodies and glycoproteins, today announced the closing of a license agreement with Bayer AG for the GlymaxX® …
OXFORD, UK, August 30, 2019 / B3C newswire / -- Orbit Discovery, an Oxford, UK-based biotech company developing an industry-leading peptide discovery platform, are pleased to announce that Dr Mario Polywka has joined their board as a non-executive director …
RENO, Nevada, USA, August 28, 2019 / B3C newswire / -- rfxcel, the global leader in supply chain track and trace solutions, today announced that it had doubled the size of its workforce in Russia and was pursuing deals in new industries, continuing its …
HEIDELBERG, Germany, August 27, 2019 / B3C newswire / -- Velabs Therapeutics, specializing in the fast generation of functional therapeutic antibodies, today announced that its cooperation with Chiome Bioscience, Inc., Tokyo, will be deepened, to jointly …
OXFORD, UK, August 27, 2019 / B3C newswire / -- Vaccitech, a clinical-stage T cell immunotherapy company developing products to treat and prevent cancer and infectious diseases (ID), announced today that it has appointed Bill Enright as its new Chief …
RENO, Nevada, USA, August 22, 2019 / B3C newswire / -- rfxcel, the global leader in supply chain track and trace solutions, will exhibit at this year’s CPhI Middle East & Africa (MEA) conference in Abu Dhabi, United Arab Emirates. The company is …
DRESDEN, Germany, August 22, 2019 / B3C newswire / -- Due to their high accessibility and extensive beneficial properties, human Mesenchymal Stem Cells (hMSC) offer exciting promises in a plethora of applications in regenerative medicine, particularly in …
LONDON, UK, August 21, 2019 / B3C newswire / -- Rexgenero, a regenerative medicine company pioneering the development of advanced cell-based therapies to treat chronic limb-threatening ischaemia (CLI), welcomes the news announced today by Atelerix that it …
The company meets aggressive timelines for new manufacturing facility LEIDEN, the Netherlands, August 09, 2019 / B3C newswire / -- HALIX, a contract development and manufacturing organization of clinical and commercial proteins and viral products, based in …
Integrated package of new and established services saves time and minimizes risks GOETTINGEN, Germany and GLASGOW, UK, August 08, 2019 / B3C newswire / -- Sartorius Stedim Biotech (SSB), a leading partner of the biopharmaceutical industry, today announced …
FREIBURG, Germany, August 05, 2019 / B3C newswire / -- The owners of Cytena GmbH ("Cytena") have agreed to sell all Cytena shares to CELLINK AB ("CELLINK") for a purchase price of 30.25M euros ("acquisition"). Through CELLINK’ …
03 days 22:07:06
